Market Cap 4.67M
Revenue (ttm) 0.00
Net Income (ttm) -24.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 45,362
Avg Vol 302,872
Day's Range N/A - N/A
Shares Out 5.09M
Stochastic %K 29%
Beta 1.31
Analysts Hold
Price Target $50.00

Company Profile

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nanocrystals for the delivery of small molecules, nucleic acids, gene therapies, vaccines, proteins, and peptides. Its lead product candidate is MAT2203, an oral formulation of amphotericin B that is starting Phase 3 clinical trials for the treatment of asp...

Industry: Biotechnology
Sector: Healthcare
Phone: 908 484 8805
Address:
1545 Route 206 South, Suite 302, Bedminster, United States
NextBigRun
NextBigRun Jul. 6 at 11:00 PM
$MTNB 👀
0 · Reply
tdohm22
tdohm22 Jul. 2 at 7:20 PM
$MTNB why are we not getting price action on 2 new analogs this week. The market has spoken on “platform technologies.” In my honest opinion…both are inferior platforms with less upside and less exclusivity. CureVac: $1.25B Capstan: $2.1B And we can’t even hold $5M.
0 · Reply
tdohm22
tdohm22 Jul. 2 at 5:24 AM
$MTNB the rapid shifts from unadulterated fatalism and feeling certain without doubt (and I am one who doubts heavily in life) in-which I see hundreds of billions in untapped/unmet market share trading at a $5M valuation is somedays just too much. It’s nauseating. It’s debilitating. It’s obsession. I know I’m not wrong…and yet, everyday…I am wrong. Rotations come and go throughout every single asset on the market. But not here…never a chance to pay myself something by betting on a technology theorized from 1975-1997…and put into the clinical apparatus from 1997-2025. LNC has hit every mark. MAT2203 has hit every mark. Our compassionate cases have hit every mark. A pedigree of scientists and business men and women never seen in a nano-cap, before…not in the modern market. I will once again wake up…hit with sheer disappointment as any gain is always erased (6-10 years)….but I will buy more….and then more…and then some more….until the Wonder is extinguished or rectified.
0 · Reply
tdohm22
tdohm22 Jul. 1 at 6:01 PM
$MTNB going for a swim….if we aren’t above $1.25 when I’m done we are going for a due diligence ride.
0 · Reply
tdohm22
tdohm22 Jul. 1 at 5:20 PM
$MTNB they f*cking us good today boys and girls!!!! Chase those RNA rabbits!!!
0 · Reply
tdohm22
tdohm22 Jul. 1 at 4:00 PM
0 · Reply
Daveo460
Daveo460 Jun. 29 at 8:41 PM
$MTNB are there any longs left in here?
4 · Reply
Mario0812
Mario0812 Jun. 24 at 7:56 PM
$MTNB On June 23, 2025, Matinas BioPharma Holdings, Inc. held its annual meeting where stockholders approved the 2025 Equity Incentive Plan, which had been previously approved by the board on April 30, 2025. The meeting also saw the election of board members and approval of executive compensation, amendments for reverse stock splits, and an increase in authorized shares, indicating strategic moves to enhance corporate governance and financial flexibility.
0 · Reply
LegendaryCharts
LegendaryCharts Jun. 18 at 5:04 PM
$MTNB Added
0 · Reply
homaid10
homaid10 Jun. 18 at 3:29 PM
$MTNB thoughts ?
0 · Reply
Latest News on MTNB
Matinas BioPharma Receives NYSE Noncompliance Notice

Jan 10, 2025, 5:15 PM EST - 6 months ago

Matinas BioPharma Receives NYSE Noncompliance Notice


Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

Oct 12, 2023, 11:26 AM EDT - 1 year ago

Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

ANVS AVTX TPST


NextBigRun
NextBigRun Jul. 6 at 11:00 PM
$MTNB 👀
0 · Reply
tdohm22
tdohm22 Jul. 2 at 7:20 PM
$MTNB why are we not getting price action on 2 new analogs this week. The market has spoken on “platform technologies.” In my honest opinion…both are inferior platforms with less upside and less exclusivity. CureVac: $1.25B Capstan: $2.1B And we can’t even hold $5M.
0 · Reply
tdohm22
tdohm22 Jul. 2 at 5:24 AM
$MTNB the rapid shifts from unadulterated fatalism and feeling certain without doubt (and I am one who doubts heavily in life) in-which I see hundreds of billions in untapped/unmet market share trading at a $5M valuation is somedays just too much. It’s nauseating. It’s debilitating. It’s obsession. I know I’m not wrong…and yet, everyday…I am wrong. Rotations come and go throughout every single asset on the market. But not here…never a chance to pay myself something by betting on a technology theorized from 1975-1997…and put into the clinical apparatus from 1997-2025. LNC has hit every mark. MAT2203 has hit every mark. Our compassionate cases have hit every mark. A pedigree of scientists and business men and women never seen in a nano-cap, before…not in the modern market. I will once again wake up…hit with sheer disappointment as any gain is always erased (6-10 years)….but I will buy more….and then more…and then some more….until the Wonder is extinguished or rectified.
0 · Reply
tdohm22
tdohm22 Jul. 1 at 6:01 PM
$MTNB going for a swim….if we aren’t above $1.25 when I’m done we are going for a due diligence ride.
0 · Reply
tdohm22
tdohm22 Jul. 1 at 5:20 PM
$MTNB they f*cking us good today boys and girls!!!! Chase those RNA rabbits!!!
0 · Reply
tdohm22
tdohm22 Jul. 1 at 4:00 PM
0 · Reply
Daveo460
Daveo460 Jun. 29 at 8:41 PM
$MTNB are there any longs left in here?
4 · Reply
Mario0812
Mario0812 Jun. 24 at 7:56 PM
$MTNB On June 23, 2025, Matinas BioPharma Holdings, Inc. held its annual meeting where stockholders approved the 2025 Equity Incentive Plan, which had been previously approved by the board on April 30, 2025. The meeting also saw the election of board members and approval of executive compensation, amendments for reverse stock splits, and an increase in authorized shares, indicating strategic moves to enhance corporate governance and financial flexibility.
0 · Reply
LegendaryCharts
LegendaryCharts Jun. 18 at 5:04 PM
$MTNB Added
0 · Reply
homaid10
homaid10 Jun. 18 at 3:29 PM
$MTNB thoughts ?
0 · Reply
Plain360
Plain360 Jun. 17 at 11:27 PM
I bought small positions in $MTNB, $DRCT, $CGBS, $TOVX, $NUWE, $NEHC, $EPWK also bought 10 call options for $TMC that expire in Jan. 26. Watching lots of others, but these are the ones I will be invested in til they move up. Good luck and God Bless.
0 · Reply
mdrins00
mdrins00 Jun. 17 at 7:08 PM
$MTNB EYEN, another failed biotech, just announced their $ HYPE treasury. frankly....MTNB should have been first mover on this, as all they've been pedaling for years is hype. well, maybe JJ is thinking a $ POOCOIN treasury reserve? that would be appropriate as well.
0 · Reply
Plain360
Plain360 Jun. 17 at 6:03 PM
$MTNB In at .945
0 · Reply
homaid10
homaid10 Jun. 17 at 3:14 PM
$MTNB let's go guys buy buy buy
0 · Reply
GravyTrain1
GravyTrain1 Jun. 17 at 7:51 AM
0 · Reply
homaid10
homaid10 Jun. 16 at 8:51 PM
$MTNB let's go
0 · Reply
TradeUps
TradeUps Jun. 16 at 2:35 PM
$MTNB just like I said...
0 · Reply
Abo_Hamza
Abo_Hamza Jun. 16 at 2:29 PM
$MTNB it is the same am sorry 😂
1 · Reply
HansDampf1
HansDampf1 Jun. 16 at 2:20 PM
$MTNB 06.23.2025 Shareholder meeting
1 · Reply
Abo_Hamza
Abo_Hamza Jun. 16 at 2:17 PM
$MTNB mmmmm look different than usual move !!!!!!!
0 · Reply
TradeUps
TradeUps Jun. 16 at 2:13 PM
$MTNB seeing a bunch of mid-point priced trades and sub-penny priced trades.. algo fuckery by institutions.. nothing more.. tread carefully
0 · Reply
Abo_Hamza
Abo_Hamza Jun. 16 at 2:04 PM
$MTNB ??????!!!! Again 😂
0 · Reply